{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:05:02Z","timestamp":1790643902046,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04471-0","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:29:31Z","timestamp":1783380571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Geographical, institutional and workplace variability in genetic evaluation, screening practices, multidisciplinary care, and lung transplantation management for familial interstitial lung disease"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2835-300X","authenticated-orcid":false,"given":"Emil Vilstrup","family":"Moen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kreuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim A","family":"Wuyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Molina-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Wijsenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sissel","family":"Kronborg-White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna Makholm","family":"\u00d8sterg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni\u00f3","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyrios","family":"Tzouvelekis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Ryerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivette","family":"Buendia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Morisett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin M.","family":"Oldham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren K.","family":"Troy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Funke-Chambour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Borie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon L.F.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujeet","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kondoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yet H.","family":"Khor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Bendstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"153","key":"4471_CR1","doi-asserted-by":"publisher","first-page":"190053","DOI":"10.1183\/16000617.0053-2019","volume":"28","author":"R Borie","year":"2019","unstructured":"Borie R, Le Guen P, Ghanem M, Taill\u00e9 C, Dupin C, Dieud\u00e9 P, Kannengiesser C, Crestani B. The genetics of interstitial lung diseases. Eur Respir Rev. 2019;28(153):190053.","journal-title":"Eur Respir Rev"},{"issue":"4","key":"4471_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1164\/rccm.202401-0238SO","volume":"210","author":"A Adegunsoye","year":"2024","unstructured":"Adegunsoye A, Kropski JA, Behr J, Blackwell TS, Corte TJ, Cottin V, Glanville AR, Glassberg MK, Griese M, Hunninghake GM, et al. Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine. Am J Respir Crit Care Med. 2024;210(4):401\u201323.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"4471_CR3","doi-asserted-by":"publisher","first-page":"2201383","DOI":"10.1183\/13993003.01383-2022","volume":"61","author":"R Borie","year":"2023","unstructured":"Borie R, Kannengiesser C, Antoniou K, Bonella F, Crestani B, Fabre A, Froidure A, Galvin L, Griese M, Grutters JC et al. European Respiratory Society statement on familial pulmonary fibrosis. Eur Respir J. 2023;61(3):2201383.","journal-title":"Eur Respir J"},{"issue":"2","key":"4471_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.chest.2022.03.023","volume":"162","author":"CA Newton","year":"2022","unstructured":"Newton CA, Oldham JM, Applegate C, Carmichael N, Powell K, Dilling D, Schmidt SL, Scholand MB, Armanios M, Garcia CK, et al. The Role of Genetic Testing in Pulmonary Fibrosis: A Perspective From the Pulmonary Fibrosis Foundation Genetic Testing Work Group. Chest. 2022;162(2):394\u2013405.","journal-title":"Chest"},{"issue":"144","key":"4471_CR5","doi-asserted-by":"publisher","first-page":"160122","DOI":"10.1183\/16000617.0122-2016","volume":"26","author":"R Borrie","year":"2017","unstructured":"Borie R, Kannengiesser C, Sicre de Fontbrune F, Gouya L, Nathan N, Crestani B. Management of suspected monogenic lung fibrosis in a specialised centre. Eur Respir Rev. 2017;26(144):160122","journal-title":"Eur Respir Rev"},{"issue":"10","key":"4471_CR6","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1164\/rccm.201908-1571OC","volume":"201","author":"GM Hunninghake","year":"2020","unstructured":"Hunninghake GM, Quesada-Arias LD, Carmichael NE, Martinez Manzano JM, Poli De Fr\u00edas S, Baumgartner MA, DiGianni L, Gampala-Sagar SN, Leone DA, Gulati S, et al. Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis. Am J Respir Crit Care Med. 2020;201(10):1240\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"4471_CR7","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1164\/rccm.200408-1104OC","volume":"172","author":"MP Steele","year":"2005","unstructured":"Steele MP, Speer MC, Loyd JE, Brown KK, Herron A, Slifer SH, Burch LH, Wahidi MM, Phillips JA 3rd, Sporn TA, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med. 2005;172(9):1146\u201352.","journal-title":"Am J Respir Crit Care Med"},{"key":"4471_CR8","doi-asserted-by":"publisher","first-page":"1747200","DOI":"10.3389\/fmed.2026.1747200","volume":"Volume 13 - 202","author":"AP Hern\u00e1ndez Cristiancho","year":"2026","unstructured":"Hern\u00e1ndez Cristancho AP, Planas-Cerezales L, Molina-Molina M, Borie R, Wuyts WA, Jodar M, Sellares J, Hernandez-Gonzalez F. Familial interstitial lung disease: emerging insights into screening and genetic risk. Front Med. 2026;13:1747200.","journal-title":"Frontiers in Medicine"},{"issue":"16","key":"4471_CR9","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","volume":"364","author":"MA Seibold","year":"2011","unstructured":"Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, Fingerlin TE, Zhang W, Gudmundsson G, Groshong SD, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med. 2011;364(16):1503\u201312.","journal-title":"N Engl J Med"},{"issue":"8","key":"4471_CR10","doi-asserted-by":"publisher","first-page":"e70621","DOI":"10.1371\/journal.pone.0070621","volume":"8","author":"R Borie","year":"2013","unstructured":"Borie R, Crestani B, Dieude P, Nunes H, Allanore Y, Kannengiesser C, Airo P, Matucci-Cerinic M, Wallaert B, Israel-Biet D, et al. The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population. PLoS ONE. 2013;8(8):e70621.","journal-title":"PLoS ONE"},{"issue":"159","key":"4471_CR11","doi-asserted-by":"publisher","first-page":"200085","DOI":"10.1183\/16000617.0085-2020","volume":"30","author":"CHM van Moorsel","year":"2021","unstructured":"van Moorsel CHM, van der Vis JJ, Grutters JC. Genetic disorders of the surfactant system: focus on adult disease. Eur Respir Rev. 2021;30(159):200085.","journal-title":"Eur Respir Rev"},{"issue":"6","key":"4471_CR12","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1183\/13993003.02115-2015","volume":"48","author":"R Borie","year":"2016","unstructured":"Borie R, Tab\u00e8ze L, Thabut G, Nunes H, Cottin V, Marchand-Adam S, Prevot G, Tazi A, Cadranel J, Mal H, et al. Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis. Eur Respir J. 2016;48(6):1721\u201331.","journal-title":"Eur Respir J"},{"issue":"6","key":"4471_CR13","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1183\/13993003.00308-2016","volume":"48","author":"CA Newton","year":"2016","unstructured":"Newton CA, Batra K, Torrealba J, Kozlitina J, Glazer CS, Aravena C, Meyer K, Raghu G, Collard HR, Garcia CK. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur Respir J. 2016;48(6):1710\u201320.","journal-title":"Eur Respir J"},{"issue":"4","key":"4471_CR14","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.healun.2014.11.010","volume":"34","author":"R Borie","year":"2015","unstructured":"Borie R, Kannengiesser C, Hirschi S, Le Pavec J, Mal H, Bergot E, Jouneau S, Naccache JM, Revy P, Boutboul D, et al. Severe hematologic complications after lung transplantation in patients with telomerase complex mutations. J Heart Lung Transpl. 2015;34(4):538\u201346.","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"4471_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1183\/09031936.00060014","volume":"44","author":"LL Silhan","year":"2014","unstructured":"Silhan LL, Shah PD, Chambers DC, Snyder LD, Riise GC, Wagner CL, Hellstr\u00f6m-Lindberg E, Orens JB, Mewton JF, Danoff SK, et al. Lung transplantation in telomerase mutation carriers with pulmonary fibrosis. Eur Respir J. 2014;44(1):178\u201387.","journal-title":"Eur Respir J"},{"key":"4471_CR16","doi-asserted-by":"publisher","first-page":"695919","DOI":"10.3389\/fmed.2021.695919","volume":"8","author":"L Planas-Cerezales","year":"2021","unstructured":"Planas-Cerezales L, Arias-Salgado EG, Berastegui C, Montes-Worboys A, Gonz\u00e1lez-Montelongo R, Lorenzo-Salazar JM, Vicens-Zygmunt V, Garcia-Moyano M, Dorca J, Flores C, et al. Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction. Front Med (Lausanne). 2021;8:695919.","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"4471_CR17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/resp.14303","volume":"27","author":"M Terwiel","year":"2022","unstructured":"Terwiel M, Borie R, Crestani B, Galvin L, Bonella F, Fabre A, Froidure A, Griese M, Grutters JC, Johannson K, et al. Genetic testing in interstitial lung disease: An international survey. Respirology. 2022;27(9):747\u201357.","journal-title":"Respirology"},{"issue":"1","key":"4471_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12890-025-03532-0","volume":"25","author":"EV Moen","year":"2025","unstructured":"Moen EV, Prior TS, Kreuter M, Wuyts WA, Molina-Molina M, Wijsenbeek M, Morais A, Tzouvelekis A, Ryerson CJ, Caro F, et al. Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international survey. BMC Pulm Med. 2025;25(1):59.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"4471_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13023-019-1256-5","volume":"14","author":"R Borie","year":"2019","unstructured":"Borie R, Kannengiesser C, Gouya L, Dupin C, Amselem S, Ba I, Bunel V, Bonniaud P, Bouvry D, Cazes A, et al. Pilot experience of multidisciplinary team discussion dedicated to inherited pulmonary fibrosis. Orphanet J Rare Dis. 2019;14(1):280.","journal-title":"Orphanet J Rare Dis"},{"key":"4471_CR20","doi-asserted-by":"crossref","unstructured":"Franco G, Kannengiesser C, Nathan N, Lassus A, Guerin C, Ba I, Froidure A, Manali E, Brunel V, Bonniaud P et al. Impact of genetic multidisciplinary team discussion on lung fibrosis. 2024.","DOI":"10.1183\/13993003.congress-2024.PA4289"},{"key":"4471_CR21","first-page":"100948","volume":"83","author":"V Cottin","year":"2023","unstructured":"Cottin V, Bonniaud P, Cadranel J, Crestani B, Jouneau S, Marchand-Adam S, Nunes H, W\u00e9meau-Stervinou L, Bergot E, Blanchard E, et al. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis\u2009\u2013\u20092021 update. Full-length version. Respir Med Res. 2023;83:100948.","journal-title":"Respir Med Res"},{"issue":"3","key":"4471_CR22","doi-asserted-by":"publisher","first-page":"2500788","DOI":"10.1183\/13993003.00788-2025","volume":"66","author":"N Ng","year":"2025","unstructured":"Ng N, Molina-Molina M, Adegunsoye A, Borie R, Newton CA, Raby B, Zhang D, Padilla M, Crestani B, Horwitz MS et al. Genetics of interstitial lung diseases: a state-of-the-art review. Eur Respir J. 2025;66(3):2500788.","journal-title":"Eur Respir J"},{"issue":"4","key":"4471_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2471\/BLT.24.293053","volume":"103","author":"N Bergen","year":"2025","unstructured":"Bergen N, Kirkby K, Nambiar D, Schlotheuber A, Hosseinpoor AR. Monitoring of health inequalities to improve health equity. Bull World Health Organ. 2025;103(4):231\u2013a231.","journal-title":"Bull World Health Organ"},{"key":"4471_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.rmed.2017.03.020","volume":"126","author":"D Bennett","year":"2017","unstructured":"Bennett D, Mazzei MA, Squitieri NC, Bargagli E, Refini RM, Fossi A, Volterrani L, Rottoli P. Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns. Respir Med. 2017;126:75\u201383.","journal-title":"Respir Med"},{"issue":"1","key":"4471_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12890-019-0895-6","volume":"19","author":"E Krauss","year":"2019","unstructured":"Krauss E, Gehrken G, Drakopanagiotakis F, Tello S, Dartsch RC, Maurer O, Windhorst A, von der Beck D, Griese M, Seeger W, et al. Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF). BMC Pulm Med. 2019;19(1):130.","journal-title":"BMC Pulm Med"},{"issue":"6","key":"4471_CR26","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1378\/chest.127.6.2034","volume":"127","author":"HL Lee","year":"2005","unstructured":"Lee HL, Ryu JH, Wittmer MH, Hartman TE, Lymp JF, Tazelaar HD, Limper AH. Familial idiopathic pulmonary fibrosis: clinical features and outcome. Chest. 2005;127(6):2034\u201341.","journal-title":"Chest"},{"key":"4471_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-genom-082908-150046","volume":"10","author":"M Armanios","year":"2009","unstructured":"Armanios M. Syndromes of telomere shortening. Annu Rev Genomics Hum Genet. 2009;10:45\u201361.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"21","key":"4471_CR28","doi-asserted-by":"publisher","first-page":"5607","DOI":"10.1182\/blood-2010-11-322149","volume":"117","author":"EM Parry","year":"2011","unstructured":"Parry EM, Alder JK, Qi X, Chen JJ, Armanios M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood. 2011;117(21):5607\u201311.","journal-title":"Blood"},{"issue":"6","key":"4471_CR29","doi-asserted-by":"publisher","first-page":"e20200032","DOI":"10.36416\/1806-3756\/e20200032","volume":"46","author":"D Bennett","year":"2020","unstructured":"Bennett D, Fossi A, Lanzarone N, Vita E, Luzzi L, Paladini P, Bargagli E, Rottoli P, Sestini P. Lung transplant in patients with familial pulmonary fibrosis. J Bras Pneumol. 2020;46(6):e20200032.","journal-title":"J Bras Pneumol"},{"issue":"10","key":"4471_CR30","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.healun.2015.05.002","volume":"34","author":"S Tokman","year":"2015","unstructured":"Tokman S, Singer JP, Devine MS, Westall GP, Aubert JD, Tamm M, Snell GI, Lee JS, Goldberg HJ, Kukreja J, et al. Clinical outcomes of lung transplant recipients with telomerase mutations. J Heart Lung Transpl. 2015;34(10):1318\u201324.","journal-title":"J Heart Lung Transpl"},{"issue":"3","key":"4471_CR31","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.chest.2019.03.030","volume":"156","author":"AC Swaminathan","year":"2019","unstructured":"Swaminathan AC, Neely ML, Frankel CW, Kelly FL, Petrovski S, Durheim MT, Bush E, Snyder L, Goldstein DB, Todd JL, et al. Lung Transplant Outcomes in Patients With Pulmonary Fibrosis With Telomere-Related Gene Variants. Chest. 2019;156(3):477\u201385.","journal-title":"Chest"},{"issue":"5","key":"4471_CR32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.healun.2021.11.008","volume":"41","author":"JK Alder","year":"2022","unstructured":"Alder JK, Sutton RM, Iasella CJ, Nouraie M, Koshy R, Hannan SJ, Chan EG, Chen X, Zhang Y, Brown M, et al. Lung transplantation for idiopathic pulmonary fibrosis enriches for individuals with telomere-mediated disease. J Heart Lung Transpl. 2022;41(5):654\u201363.","journal-title":"J Heart Lung Transpl"},{"issue":"8","key":"4471_CR33","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.healun.2017.02.005","volume":"36","author":"CA Newton","year":"2017","unstructured":"Newton CA, Kozlitina J, Lines JR, Kaza V, Torres F, Garcia CK. Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival. J Heart Lung Transpl. 2017;36(8):845\u201353.","journal-title":"J Heart Lung Transpl"},{"issue":"6","key":"4471_CR34","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.resinv.2024.09.008","volume":"62","author":"M Asami-Noyama","year":"2024","unstructured":"Asami-Noyama M, Hamada K, Asai Y, Abe T, Yonezawa K, Watanabe M, Hisamoto Y, Murakawa K, Fukatsu A, Matsuda K, et al. Factors associated with non-intervention of antifibrotic agents in IPF patients. Respir Investig. 2024;62(6):1124\u201331.","journal-title":"Respir Investig"},{"issue":"2","key":"4471_CR35","doi-asserted-by":"publisher","first-page":"00899-2024","DOI":"10.1183\/23120541.00899-2024","volume":"11","author":"G Lough","year":"2025","unstructured":"Lough G, Abdulqawi R, Amanda G, Antoniou K, Azuma A, Baldi M, Bayoumy A, Behr J, Bendstrup E, Bouros D et al. The interstitial lung disease patient pathway: from referral to diagnosis. ERJ Open Res. 2025;11(2):00899\u20132024.","journal-title":"ERJ Open Res"},{"issue":"9","key":"4471_CR36","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, Kreuter M, Lynch DA, Maher TM, Martinez FJ, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"key":"4471_CR37","unstructured":"Overview of Mandatory Reporting, The Danish Health Research Ethics Committee system. https:\/\/www.videnskabsetik.dk\/ansoegning-til-etisk-komite\/overblik-over-anmeldelsespligten\/hvad-skal-ikke-anmeldes. [ Accessed 7 march 2026 ]."}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04471-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04471-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04471-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:46:46Z","timestamp":1790642806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04471-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4471"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04471-0","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in Denmark, and was a health science survey questionnaire, and was not subject to medical research involving human biological material. According to Danish Legislation no registration details were therefore required [\n                      \n                      ]. In this study, participants were not subject to procedures and participated voluntarily. To ensure the anonymity of the participants no email addresses were collected, participants were issued a code number, and limited data were collected. It was therefore exempted from research ethics approval according to Danish legislation [\n                      \n                      ]. Prior to participating in the survey, the respondents were informed on the study, handling of the data, and gave consent to participate when accepting to participate in the survey. All respondents were free to participate in the survey and skip any questions. The study was conducted in accordance with the Declaration of Helsinki, but was exempted for research ethics approval according to Danish legislation since this study was a health science survey questionnaire, and was not subject to medical research involving human biological material and all participants gave consent prior to participating and were kept anonymous [\n                      \n                      ].","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Thomas Prior has received honoraria for steering committee of scientific meetings from Boehringer Ingelheim, support for attending international meetings from Boehringer Ingelheim and lecture fees from Boehringer Ingelheim. Michael Kreuter has received grants and fees for consulting and lectures from BI, Roche, GSK and AstraZeneca. Wim A Wuyts has received grants or consultancy or speaker fees from Boehriner Ingelheim, Roche, Galapagos, Sanofi, Alentis, Pliant, Insilico, all payed to the institution. Maria Molina-Molina has received grants and fees for scientific advises from Boehringer, Roche, Ferrer and Chiesi. Marlies Wijsenbeek has received grants and fees for consulting and lectures from Astra Zeneca, Bristol Myers Squibb, Boehringer Ingelheim, Galapagos, Galecto, GSK, Hoffman la Roche, Horizon therapeutics, Kinevant Sciences, Molecure, Nerre Therapeutics, Novartis, PureTech Health, Thyron, Trevi, Vicore. Janne M\u00f8ller has received honoraria for lectures and support for attending international meetings from Boehringer Ingelheim. Sissel Kronborg-White has received grants from Roche and fees for lectures from Boehringer Ingelheim, Daichii-Sankyo, AstraZeneca and travel support from Boehringer Ingelheim, Nanna Makholm \u00d8sterg\u00e5rd has received grants and fees for consulting and lectures from Chiesi and Boehringer Ingelheim. Antoni\u00f3 Morias has received grants and fees for scientific advice or speaker fees from Roche, Boehringer Ingelheim, Bial, GSK and Sanofi-Aventis. Christopher J. Ryerson has received consulting fees from Boehringer-Ingelheim, Pliant Therapeutics, Astra Zeneca, Trevi Therapeutics, Veracyte and honoraria for lectures from Hofmann-La Roche and Boehringer-Ingelheim. Jesper Magnusson has received research grants from Boehringer-Ingelheim and consulting fees from Boehringer Ingelheim, AstraZeneca, Takada Pharma, Vicore Pharma Mallinckrodt, Chiesi Pharma and Unimedic Pharma. Joyce Lee has received grants from the NIH and Boehringer-Ingelheim, unrestricted research gift from Pliant and consulting fees from Blade, Boehringer Ingelheim, United Therapeutics, Astra Zeneca, Elima and Eleven P15. Justin Oldham have received consulting fees from Boehringer-Ingelheim and Roche. Lauren K. Troy have received speaker fees from Boehringer-Ingelheim and grant support from the NHMRC Centre of Research Excellence in Pulmonary Fibrosis. Manuela Funke-Chambour has received research support from BI, BMS, AstraZeneca, advisory board, consultancy fees from BI, MSD, GSK, Pfizer, Roche, Sanofi. Presentations: BI, Astra, GSK. Raphael Borie has received consulting fees from Boehringer-Ingelheim, Ferrer and Sanofi. Honoria for lectures from Boehringer-Ingelheim. Yasuhiro Kondoh serves as a consultant to Asahi Kasei Pharma Corp., Shionogi & Co.Ltd., Boehringer Ingelheim Co., Ltd., Janssen Pharmaceutical K.K., Healios K.K., Chugai Pharmaceutical Co., Ltd., and Taiho Pharmaceutical Co., Ltd., received lecture fees from Asahi Kasei Pharma Corp., Shionogi & Co.Ltd., and Boehringer Ingelheim Co., Ltd., AstraZaneca K.K, Eisai inc., KYORIN Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma, and Novartis Pharma K.k., outside the presentation work. Yet. H Khor has received grants from NHMRC Investigator Grant during the conduct of the study and non-financial support from the Air Liquide Healthcare outside the submitted work. Elisabeth Bendstrup has received fees for presentations for Boehringer-Ingelheim, Bristol Myers Squibb, AstraZeneca, Novartis. Advisory board meeting Boehringer-Ingelheim, travel support from Boehringer-Ingelheim. The other authors have nothing to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"439"}}